Gastroparesis Scan: What It Shows, Cost & Preparation on GASTRIC-EMPTYING-SCAN: What It Means & Next Steps

Understanding Gastroparesis Scan

Gastroparesis literally means "stomach paralysis"—a chronic condition where the stomach cannot empty normally in the absence of mechanical obstruction. The stomach's muscular contractions become weak, uncoordinated, or absent, preventing normal grinding and propulsion of food into the small intestine.

The hallmark symptoms—chronic nausea, vomiting, early satiety (feeling full quickly), abdominal bloating, and upper abdominal pain—significantly impair quality of life. Gastric emptying scintigraphy provides objective confirmation when these symptoms are present, distinguishing true gastroparesis from functional dyspepsia and other upper GI disorders.

Markedly delayed gastric emptying with >70% retention at 2 hours (normal <10%) confirms gastroparesis and guides selection of prokinetic medications and potential advanced therapies

How Gastroparesis Scan Works

The scan measures the stomach's ability to empty a standardized radiolabeled meal:

Standardized test meal (ANMS/ACG consensus protocol):

Egg white sandwich with jam OR oatmeal

Labeled with technetium-99m sulfur colloid (0.5-1 mCi)

Radiotracer binds firmly to the food proteins

Patient eats entire meal within 10 minutes

Imaging protocol (4-hour study):

Time 0 : Immediately after eating (100% gastric retention)

Serial images : At 0, 30, 60, 120, and 240 minutes

Anterior/posterior views : Correct for attenuation

Geometric mean : Calculated for accuracy

Diagnostic criteria (at 2 hours):

Normal : ＜10% retention

Mild gastroparesis : 10-15% retention

Moderate gastroparesis : 15-25% retention

Severe gastroparesis : ＞25% retention

At 4 hours (confirmatory):

Normal : ＜5% retention

Abnormal : ＞10% retention

Gold standard diagnostic test

Correctly rules out healthy patients

Annual new cases

Clinical Patterns

Diabetic Gastroparesis

Diabetes is the most common identifiable cause :

Pathophysiology :

Chronic hyperglycemia damages vagus nerve fibers

Autonomic neuropathy impairs stomach motility

Hyperglycemia itself slows gastric emptying (vicious cycle)

Advanced glycation end products damage stomach muscle

Typical presentation :

Long-standing diabetes (＞10 years)

Other microvascular complications present

Erratic blood glucose levels

Difficulty matching insulin to meals

Prognosis :

Generally progressive if diabetes poorly controlled

Better outcomes with tight glycemic control

May require insulin regimen adjustments

Post-Surgical Gastroparesis

After gastric operations :

Fundoplication : Alters gastric compliance and fundic function

Bariatric surgery : Sleeve gastrectomy or gastric bypass effects

Gastrectomy : Reduced stomach capacity and innervation

Vagotomy : Intentional or accidental nerve damage

Onset patterns :

Immediate: Post-surgical inflammation or nerve damage

Delayed: Scarring or adhesion formation

Idiopathic Gastroparesis

Unknown cause (30-40% of cases):

More common in women (4:1 female predominance)

Often follows viral gastroenteritis ("post-viral")

May have autoimmune component

Some patients have gradual insidious onset

Clinical features :

Similar symptoms to diabetic gastroparesis

Often younger patients

May have better prognosis than diabetic form

Secondary Gastroparesis

Other medical conditions :

Neurological : Parkinson's disease, MSA, stroke

Connective tissue : Scleroderma, lupus, Sjogren's

Metabolic : Hypothyroidism, uremia

Medications : Opioids, GLP-1 agonists, tricyclics, anticholinergics

Clinical Scenario

Normal Gastric Emptying

Progressive gradual emptying with normal gastric emptying curve. At 1 hour: 50% retention. At 2 hours: 8% retention. At 4 hours: 3% retention. Normal T1/2 of ~80 minutes. Small bowel fills appropriately. Stomach size normal throughout.

Severe Gastroparesis

Markedly delayed emptying with 90% retention at 1 hour, 75% at 2 hours (normal <10%), and 40% at 4 hours (normal <5%). Stomach appears dilated with minimal intestinal activity throughout entire study. T1/2 >250 minutes. Findings indicate severe gastroparesis.

Clinical Applications

Diagnostic Confirmation

Confirming gastroparesis :

Distinguishes from functional dyspepsia

Identifies mechanical obstruction (if any)

Provides objective diagnosis for symptoms

Guides treatment selection

Severity assessment :

Mild: May respond to diet and single medication

Moderate: Requires combination therapy

Severe: May need advanced therapies or nutritional support

Treatment Monitoring

Assessing response :

Baseline study before initiating treatment

Follow-up scan after 3-6 months of therapy

Guides medication adjustments

Determines need for advanced interventions

Treatment options monitored :

Prokinetic medications (metoclopramide, erythromycin, domperidone)

Dietary modifications

Gastric electrical stimulation (Enterra therapy)

Botulinum toxin injection into pylorus

Pyloroplasty or gastrectomy (refractory cases)

Diabetes Management

Glycemic control implications :

Gastroparesis causes unpredictable glucose absorption

Makes insulin dosing challenging

Can cause both hypoglycemia and hyperglycemia

Scan guides :

Insulin regimen adjustments

Timing of prandial insulin

Need for continuous glucose monitoring

Determining when to use long-acting vs. rapid-acting insulin

What Else Could It Be?

Delayed gastric emptying &gt;10% at 4 hours with characteristic symptoms. Excludes mechanical obstruction. May have diabetic, post-surgical, or idiopathic causes.

Normal gastric emptying on scan. Similar symptoms but without objective delay. Often stress-related. Rome IV criteria apply.

Mechanical blockage from peptic ulcer, tumor, or bezoar. Endoscopy or CT shows structural lesion. May show gastric dilation without delayed emptying of liquids.

Episodic severe vomiting with symptom-free intervals. Normal gastric emptying between episodes. Associated with migraines, cannabis use, or anxiety.

Evidence-Based Outcomes

With combination therapy including prokinetic medications, dietary modifications, and glycemic optimization. Complete normalization of gastric emptying occurs in <20% of patients.

Indicates severe gastroparesis requiring aggressive management. These patients often need combination prokinetic therapy and may be candidates for gastric electrical stimulation.

Preparing for Your Scan

Fasting : Nothing to eat or drink for 6-8 hours before the test

Medications : Hold prokinetics, antiemetics, opioids for 48-72 hours

Diabetic patients : Special glucose management instructions

Planning : Bring reading material or entertainment (4-hour study)

Understanding Your Results

What Happens Next?

Prokinetic Medication

Start metoclopramide, domperidone, or erythromycin to stimulate gastric motility. Consider antiemetics for nausea control. Monitor for side effects.

Dietary Modifications

Small, frequent low-fat, low-fiber meals. Liquid or pureed diet may help initially. Avoid carbonated beverages. Consider nutritional supplements if weight loss significant.

Glycemic Optimization (Diabetics)

Adjust insulin regimen to account for delayed absorption. Consider continuous glucose monitoring. Tight glycemic control may improve gastric emptying.

Advanced Therapies (Refractory Cases)

If symptoms persist: gastric electrical stimulation (Enterra), botulinum toxin injection into pylorus, endoscopic pyloromyotomy, or surgical options.

Frequently Asked Questions

Can gastroparesis be cured?

Complete cure is uncommon, but significant symptom improvement is possible. Post-viral gastroparesis may resolve completely in some patients. Diabetic gastroparesis is typically lifelong but can be well-managed. Treatment focuses on symptom control and nutritional support.

What is the diet for gastroparesis?

Eat small, frequent meals (6 per day). Choose low-fat, low-fiber foods. Liquid or pureed foods empty more easily. Examples: smoothies, yogurt, soup, applesauce, white rice, pasta, lean proteins. Avoid high-fat foods, raw fruits/vegetables, whole grains, carbonated drinks.

How does gastroparesis affect blood sugar?

Delayed stomach emptying makes carbohydrate absorption unpredictable and delayed. This causes blood sugar to rise later than expected after eating, making insulin dosing difficult. Patients may experience hypoglycemia when insulin acts before food absorbs, or hyperglycemia when food finally empties.

When is gastric electrical stimulation used?

Gastric electrical stimulation (Enterra therapy) is considered for severe, refractory gastroparesis that hasn't responded to medications and dietary changes. The device is surgically implanted and sends mild electrical impulses to the stomach, reducing nausea and vomiting in about 60-80% of patients.

References

American College of Gastroenterology. ACG Clinical Guidelines: Diagnosis and Management of Gastroparesis. 2024.

American Neurogastroenterology and Motility Society. ANMS Consensus Guidelines: Gastric Motor Function Testing. 2023.

Parkman HP, et al. Clinical Management of Gastroparesis. American Journal of Gastroenterology. 2024.

Medical Disclaimer: This information is educational only. Always discuss findings with your healthcare provider for personalized medical advice.

🔗 Explore Related Content

Deepen your understanding with related imaging terms, lab tests, and diseases

Recommended Learning Path

Build comprehensive understanding through structured learning

Have a Gastric Emptying Scan Report?

Upload your PDF report for quick plain-language explanations of terms like "Gastroparesis Scan: What It Shows, Cost & Preparation". WellAlly helps you understand your radiology results.